September 16, 2022
Hepatologist Naim Alkhouri and Endocrinologist Scott Isaacs join Ken Cusi and Roger Green to discuss drug choices prescribers can make TODAY for patients with Type 2 Diabetes Mellitus and obesity that have positive impact on Fatty Liver disease.
Every week, a global community of Fatty Liver Disease stakeholders comes together to explore the most important challenges in diagnosing, treating, and developing medications for patients with Fatty Liver Diseases.
Join hepatology researcher and Key Opinion Leader Dr. Stephen Harrison, liver wellness advocate Louise Campbell MSc AP., Forecasting and Pricing guru Roger Green, M.B.A., and their weekly guests as they discuss these issues from their own unique perspectives on the Surfing the NASH Tsunami podcast.
Surfers Roger Green, Jörn Schattenberg and Louise Campbell embark on their first exclusive discussion together in a while without any guest panelists. After several weeks of attending and reviewing conferences, the trio take the opportunity to talk about what the next year holds for the NAFLD-metabolic disease link.
In this episode From the Vault, Jörn Schattenberg, Stephen Harrison and Roger Green review some highlights from the 2021 Paris NASH Meeting. This conversation looks at the Day Two sessions and the overall implications of the meeting.
In Part 2 of Season 3, Episode 44, host Roger Green kicks off a series of 1 on 1 interviews with friend of the podcast, Dr. Jeffrey Lazarus. In this conversation, the two discuss a preview of NAFLD Summit 2022 in Dublin, 15-17 September.
In Part 2 of this episode, host Roger Green interviews podcast friend and frequent guest, Dr. Jeffrey Lazarus. In this conversation, they discuss the NAFLD Nomenclature Conference held in July.
In this conversation, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to talk about Paris NASH 2022. The group explores their hopes in terms of immediate and long term outcomes of the meeting.
In a preview of the 2022 Paris NASH Meeting, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to discuss the opening session. The group explores potential insights that will contextualize NASH in the scope of an integrated multi-specialty approach.
In a preview of the 2022 Paris NASH Meeting, Surfers Roger Green, Louise Campbell, and Jörn Schattenberg are joined by Rachel Zayas to discuss what each looks forward to most in the upcoming panels and discussions. “Brave one go first.”
Hepatology Researcher and Key Opinion Leader Stephen Harrison discussed results of his 2021 publication in the Journal of Hepatology that
